Glipizide Patent Expiration
Glipizide is used for managing hyperglycemia in diabetes through oral administration of a once-a-day sustained release dosage form of Glipizide. It was first introduced by Pfizer Inc
Glipizide Patents
Given below is the list of patents protecting Glipizide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Glucotrol Xl | USRE44459 | Method for lowering blood glucose |
Mar 26, 2019
(Expired) | Pfizer |
| Glucotrol Xl | US5591454 | Method for lowering blood glucose |
Jan 07, 2014
(Expired) | Pfizer |
Glipizide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List